Journal of drug targeting

2.3k papers and 66.9k indexed citations i.

About

The 2.3k papers published in Journal of drug targeting in the last decades have received a total of 66.9k indexed citations. Papers published in Journal of drug targeting usually cover Molecular Biology (1.1k papers), Biomaterials (562 papers) and Pharmaceutical Science (429 papers) specifically the topics of RNA Interference and Gene Delivery (564 papers), Nanoparticle-Based Drug Delivery (513 papers) and Advanced Drug Delivery Systems (310 papers). The most active scholars publishing in Journal of drug targeting are Mitsuru Hashida, Ruth Duncan, Yadollah Omidi, Saghir Akhtar and Yoshinobu Takakura.

In The Last Decade

Fields of papers published in Journal of drug targeting

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Journal of drug targeting. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Journal of drug targeting

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Journal of drug targeting. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Journal of drug targeting with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025